Melodrama? Pretty fundamental item in my opinion.
The R&D rebate will indeed be the catalyst, but what wil the news be?
Good: As expected $7m plus, and arrives in a timely manner.
Not so good: As expected but substantially delayed
Bad: Knocked back severely because of the USA component
Very bad: Knocked back because of the above and causing delays real enough to stress the cash flow severely.
I don't mind the charts at all, but they reflect and track sentiment, and in this case the R&D funding issue and the discussions, not melodrama, are keeping the sentiment real.
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
1.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $25.76M | |||
| Open | High | Low | Value | Volume |
| 1.0¢ | 1.1¢ | 0.9¢ | $42.31K | 4.231M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 23 | 6101643 | 0.9¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 1.0¢ | 1877005 | 1 |
View Market Depth
| Last trade - 16.10pm 07/08/2025 (20 minute delay) ? |
| BLG (ASX) Chart |